Oritavancin
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Oritavancin, covering 2021-04-13 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Oritavancin for Treatment of Serious Cardiac Infections [Phase 2]